Twist Bioscience Corp (NASDAQ:TWST) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 02, 2026.
The Healthcare company reported Q0 revenue of .
Twist Bioscience Corp's stock currently trades at $46.81 with a market capitalization of $1.9B.


